MAIN PORTFOLIO, IBKR ISA ONLY
Current Portfolio
A public record of the holdings I own in my IBKR ISA, the position sizes behind them, and the thinking I am sharing as the journey develops. Trading 212 is tracked separately as the £15k High Growth Challenge.
Total portfolio value: £204,779.81 including £49.84 cash.
IBKR ISA prior-business-day close: 22 July 2026. USD positions use USD/GBP 0.747720 for indicative GBP values.
| Symbol ↕ | Name ↕ | Shares ↕ | Latest price ↕ | Position value (GBP) ↕ | Weighting ↕ |
|---|---|---|---|---|---|
| ABCL | AbCellera | 3,001 | $5.73 | £12,857.59 | 6.28% |
| AMKR | Amkor Technology | 100 | $66.97 | £5,007.48 | 2.45% |
| BETA | BETA Technologies | 1,000 | $18.33 | £13,705.71 | 6.69% |
| BMNR | BitMine | 200 | $17.74 | £2,652.91 | 1.30% |
| FTC | Filtronic | 1,000 | £2.53 | £2,530.00 | 1.24% |
| IONQ | IonQ | 50 | $34.68 | £1,296.55 | 0.63% |
| MSTR | Strategy | 70 | $100.01 | £5,234.56 | 2.56% |
| MU | Micron | 10 | $959.48 | £7,174.22 | 3.50% |
| NOW | ServiceNow | 150 | $95.46 | £10,706.60 | 5.23% |
| ONDS | Ondas | 400 | $8.00 | £2,392.70 | 1.17% |
| PLTR | Palantir | 250 | $124.57 | £23,285.87 | 11.37% |
| RKLB | Rocket Lab | 2,000 | $69.75 | £104,306.94 | 50.94% |
| SRFM | Surf Air Mobility | 13,800 | $0.81 | £8,336.35 | 4.07% |
| UBER | Uber | 100 | $70.33 | £5,258.71 | 2.57% |
| Cash | GBP Cash | – | £49.84 | £49.84 | 0.02% |
| Total portfolio value | £204,779.81 | 100.00% | |||
Tip: click any column heading to sort.
RESEARCH & INVESTMENT THESES
Explore the holdings
These links lead to company notes, investment theses and related writing. They are not buy recommendations.
PORTFOLIO WRITING
Articles on investments
Only posts filed under Investment Portfolio appear here.
-
Why I Made Rocket Lab 50% of My Portfolio
I sold smaller positions and made Rocket Lab roughly 50% of my portfolio. This is why I acted, the risks I accept and what would make me reassess.
-
AbCellera (ABCL) 2026 Investment Update: Clinical Proof Is Now the Test
My 2026 AbCellera investment update. The next clinical readouts will test whether the platform can produce evidence that changes the investment case.
-
BETA Technologies (BETA) Investment Thesis: Aircraft, Charging and Commercial Validation
My current BETA Technologies thesis centres on the ALIA aircraft, its charging ecosystem and whether early commercial relationships can turn into real deliveries.
-
NVIDIA (NVDA) Investment Thesis: Scale, Execution and Earnings Power
My current NVIDIA thesis centres on whether scale, platform execution and earnings power can continue compounding through the AI infrastructure buildout.
-
Palantir (PLTR) Investment Thesis: Why AIP Commercial Adoption Matters Most
My current Palantir thesis centres on whether AIP commercial adoption can become durable, embedded revenue rather than a short-lived AI spending cycle.
-
Amkor Technology (AMKR): Why I Started Buying at $31
Why I started building a position in Amkor Technology at around $31, and why I think the bull case is stronger than the market gives it credit for.